Poised to Deliver Breakthroughs in Oncology and CNS Bexion Pharmaceuticals is a mid-stage clinical company developing life-changing treatments in Oncology and CNS. The company’s lead compound, BXQ-350, is a novel S1P modulator. With our highly experienced biotech leadership team and expertise in Oncology, we are urgently progressing our pipeline to develop life-changing oncology therapies on our path to becoming a leading biotech/pharmaceutical company. To learn more about Bexion Pharmaceuticals, please visit Bexionpharma.com or call (859) 446-7386.
Looking for a particular Bexion Pharmaceuticals employee's phone or email?
Bexion Pharmaceuticals Questions
The Bexion Pharmaceuticals annual revenue was $2 million in 2026.
Chuck Scheper is the Chairman of the Board of Bexion Pharmaceuticals.
22 people are employed at Bexion Pharmaceuticals.
Bexion Pharmaceuticals is based in Covington, Kentucky.
The NAICS codes for Bexion Pharmaceuticals are [325, 3254, 32, 32541].
The SIC codes for Bexion Pharmaceuticals are [283, 28].
Top Bexion Pharmaceuticals Employees
-
Chuck Scheper
Chairman of the Board at Bexion Pharmaceuticals
Covington, KY, US25+ -
55
-
Margaret van Gilse
VP Business Development at Bexion Pharmaceuticals
Covington, KY, US13 -
13 -
Sandra Nelson
VP at Bexion Pharmaceuticals
Loveland, OH, US12 -
Michelle Wos
Director of Program Management at Bexion Pharmaceuticals
Cincinnati, OH, US25+ -
Kate Boggs
Director of Finance at Bexion Pharmaceuticals
Cincinnati, OH, US21 -
Tim Stephens
Laboratory Director at Bexion Pharmaceuticals
Cincinnati, OH, US12 -
Jessica Cherry
Clinical Trial Manager at Bexion Pharmaceuticals
Loveland, OH, US25+
